U.S. Gene Therapy Markets
U.S. Gene Therapy Markets
RELEASE DATE
29-Sep-2005
29-Sep-2005
REGION
North America
North America
Research Code: F414-01-00-00-00
SKU: HC01453-NA-MR_05951
$2,450.00
Special Price $1,837.50 save 25 %
In stock
SKU
HC01453-NA-MR_05951
Description
This research service covers the Gene Therapy markets across the United States. The research service provides a detailed analysis of the revenue structure across multiple vectors and delivery systems. Strategic recommendations for these have also been discussed along with revenue forecasts.
Table of Contents
Executive Summary
- Executive Summary
Introduction
- Market Overviews
- The History of Gene Therapy
- Recent Developments in Gene Therapy Research
- Toxicities and Fatalities with Gene Therapies
- Gendicine – the First Approved Gene Therapy in the World
- The Human Genome Project
Basic Genetic Terminologies and Definitions
- Objectives of Gene Therapy
- Basic Genetic Terminology
- Gene Therapy Vectors
- Gene Regulation
- Gene Therapy Targets
Introduction and Overview
Vectors in Gene Therapy
- Gene Delivery Systems
- Features of Ideal Gene Vectors
- Regulation of Transgene Expression Systems
- Gene Delivery Variables
Non-Viral Delivery Technologies in Gene Therapy
- Viral Vectors
- Retroviral Vectors
- Lentiviral Vectors
- Adenoviral Vectors
- Adeno-associated Viral (AAV) Vectors
- Vaccinia Vectors
- Herpes Simplex Virus (HSV) Vectors
- Other Viral Vectors
Novel Non-viral Gene Therapy Technologies
- Non-viral Delivery Technologies in Gene Therapy
- Calcium Phosphate and DEAE Dextran
- Liposomes
- Electroporation-mediated Gene Delivery Technology
- Naked Plasmid DNA Injection
- Compacted DNA Technology (DNA nanoparticles)
- Microinjection
- Ballistic DNA Injection
Market Overview
Market Forecasts and Competitive Analysis
Challenges and Strategic Recommendations
Awards
Introduction
Monogenic Disease Therapy
Cancer Gene Therapy
Cardiovascular Gene Therapy
Other Gene Therapies
Decision Support Databases
Related Research
Popular Topics
This research service covers the Gene Therapy markets across the United States. The research service provides a detailed analysis of the revenue structure across multiple vectors and delivery systems. Strategic recommendations for these have also been discussed along with revenue forecasts.
No Index | Yes |
---|---|
Podcast | No |
Industries | Healthcare |
WIP Number | F414-01-00-00-00 |
Is Prebook | No |